Cargando…

Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain—A retrospective observational real‐world study

BACKGROUND: Cannabinoids are considered a therapeutic option to patients suffering from treatment refractory chronic pain (TRCP) insufficiently relieved by conventional analgesics or experiencing intolerable adverse events (AEs) from those. This study aimed to explore safety and effectiveness of ora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horsted, Tina, Hesthaven, Karoline Lichon, Leutscher, Peter Derek Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107230/ https://www.ncbi.nlm.nih.gov/pubmed/36394124 http://dx.doi.org/10.1002/ejp.2054

Ejemplares similares

Is there an added value in more real‐world cannabinoids studies?
por: Eisenberg, Elon
Publicado: (2022)

Consequences from use of reminiscence - a randomised intervention study in ten Danish nursing homes
por: Gudex, Claire, et al.
Publicado: (2010)

A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products
por: Nutt, David J., et al.
Publicado: (2022)

Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis
por: Wright, William Alexander, et al.
Publicado: (2021)

Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain
por: Mondello¹, Epifanio, et al.
Publicado: (2018)

Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study
por: Hoffmann, Peter, et al.
Publicado: (2020)

Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study
por: Wang, Dahai, et al.
Publicado: (2022)

Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
por: Ntanasis-Stathopoulos, Ioannis, et al.
Publicado: (2023)

Cannabinoids in the treatment of pain
por: Kara, Eleana, et al.
Publicado: (2010)

Safety and Toxicology of Cannabinoids
por: Sachs, Jane, et al.
Publicado: (2015)

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
por: Lebel, Eyal, et al.
Publicado: (2023)

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
por: Onda, Yoshiyuki, et al.
Publicado: (2022)

PB2113: TREATMENT REFRACTORINESS AND RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA
por: Majd, Zahra, et al.
Publicado: (2023)

The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013)

Observational Safety Study of Clottafact(®) Fibrinogen Concentrate: Real-World Data in Mexico
por: Colin-Bracamontes, Ignacio, et al.
Publicado: (2020)

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma
por: Basali, Diana, et al.
Publicado: (2020)

Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
por: Arrichiello, Gianluca, et al.
Publicado: (2022)

PB2127: REAL-WORLD EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN TRIPLE CLASS REFRACTORY PATIENTS WITH MULTIPLE MYELOMA
por: Ntanasis-Stathopoulos, Ioannis, et al.
Publicado: (2023)

Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
por: Yeom, Hoseok, et al.
Publicado: (2023)

Antibiotic Practice in Patients With Acute Abdomen Admitted to a Danish Regional Hospital: A Clinical Qualitative Assurance Study
por: Ozen, Cihan, et al.
Publicado: (2023)

PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE
por: Hultcrantz, Malin, et al.
Publicado: (2023)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)

Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study
por: Gordan, Lucio, et al.
Publicado: (2021)

A joint industry‐sponsored data monitoring committee model for observational, retrospective drug safety studies in the real‐world setting
por: Major‐Pedersen, Atheline, et al.
Publicado: (2020)

Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study
por: Jiang, Ying, et al.
Publicado: (2022)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

P914: VENETOCLAX IN RELAPSE/REFRACTORY AL AMYLOIDOSIS- A MULTICENTER INTERNATIONAL RETROSPECTIVE REAL-WORLD STUDY
por: Lebel, Eyal, et al.
Publicado: (2023)

Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
por: Georgakopoulos, Jorge R., et al.
Publicado: (2021)

Cannabinoids in the management of difficult to treat pain
por: Russo, Ethan B
Publicado: (2008)

Including cannabinoids in the treatment of painful schwannomatosis
por: Iorno, Vittorio, et al.
Publicado: (2018)

High and Mighty? Cannabinoids and the microbiome in pain
por: Rea, Kieran, et al.
Publicado: (2021)

The Place of Cannabinoids in the Treatment of Gynecological Pain
por: Sinclair, Justin, et al.
Publicado: (2023)

Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
por: Zhao, Ting, et al.
Publicado: (2023)

Safety Considerations in Cannabinoid-Based Medicine
por: Gottschling, Sven, et al.
Publicado: (2020)

Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study
por: Wang, Chenyu, et al.
Publicado: (2022)

Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China
por: Yang, Jing, et al.
Publicado: (2022)

Genital warts and inflammatory bowel diseases: Danish real‐world evidence to assess patient‐relevant outcomes
por: McLellan, Paul, et al.
Publicado: (2022)

Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience
por: Barbash, Benjamin, et al.
Publicado: (2019)

P49 A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE
por: Furlan, A., et al.
Publicado: (2023)

P970: A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE
por: Furlan, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_op7nteosede3u382d2uf91475m